Gary Cutter

57.7k total citations · 11 hit papers
770 papers, 35.1k citations indexed

About

Gary Cutter is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Gary Cutter has authored 770 papers receiving a total of 35.1k indexed citations (citations by other indexed papers that have themselves been cited), including 292 papers in Pathology and Forensic Medicine, 137 papers in Neurology and 89 papers in Oncology. Recurrent topics in Gary Cutter's work include Multiple Sclerosis Research Studies (282 papers), Peripheral Neuropathies and Disorders (47 papers) and Polyomavirus and related diseases (42 papers). Gary Cutter is often cited by papers focused on Multiple Sclerosis Research Studies (282 papers), Peripheral Neuropathies and Disorders (47 papers) and Polyomavirus and related diseases (42 papers). Gary Cutter collaborates with scholars based in United States, Canada and United Kingdom. Gary Cutter's co-authors include Ruth Ann Marrie, Tuula Tyry, Stephen C. Reingold, Richard A. Rudick, Amber Salter, Timothy Vollmer, Monika Baier, Jill S. Fischer, David R. Jacobs and Denise I. Campagnolo and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Gary Cutter

728 papers receiving 33.8k citations

Hit Papers

Cardia: study design, recruitment, and some characteristi... 1988 2026 2000 2013 1988 1999 2003 1999 2019 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Cutter United States 96 13.6k 5.7k 4.1k 3.9k 3.4k 770 35.1k
Miguel A. Hernán United States 93 4.2k 0.3× 3.3k 0.6× 2.8k 0.7× 3.0k 0.8× 3.6k 1.1× 313 42.2k
Giuseppe Remuzzi Italy 144 4.9k 0.4× 1.6k 0.3× 11.0k 2.7× 4.6k 1.2× 4.7k 1.4× 1.3k 95.1k
Dirk L. Knol Netherlands 72 4.4k 0.3× 2.1k 0.4× 1.6k 0.4× 1.4k 0.3× 3.5k 1.0× 308 36.3k
Rory Collins United Kingdom 86 3.3k 0.2× 1.5k 0.3× 4.6k 1.1× 3.6k 0.9× 7.0k 2.0× 245 62.1k
Stephen Burgess United Kingdom 78 4.2k 0.3× 1.4k 0.2× 2.7k 0.7× 2.2k 0.6× 3.7k 1.1× 334 48.2k
Martha S. Linet United States 86 5.0k 0.4× 1.1k 0.2× 2.6k 0.6× 5.0k 1.3× 4.3k 1.3× 383 26.0k
L. Adrienne Cupples United States 112 2.7k 0.2× 1.9k 0.3× 2.3k 0.6× 2.3k 0.6× 5.3k 1.5× 539 43.4k
Diederick E. Grobbee Netherlands 125 4.5k 0.3× 1.3k 0.2× 9.6k 2.3× 2.8k 0.7× 7.6k 2.2× 943 64.5k
Christopher H. Schmid United States 88 3.0k 0.2× 1.2k 0.2× 7.3k 1.8× 2.8k 0.7× 5.2k 1.5× 404 63.2k
Peter C. O’Brien United States 105 3.7k 0.3× 9.5k 1.7× 2.8k 0.7× 2.3k 0.6× 1.1k 0.3× 426 39.8k

Countries citing papers authored by Gary Cutter

Since Specialization
Citations

This map shows the geographic impact of Gary Cutter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Cutter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Cutter more than expected).

Fields of papers citing papers by Gary Cutter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Cutter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Cutter. The network helps show where Gary Cutter may publish in the future.

Co-authorship network of co-authors of Gary Cutter

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Cutter. A scholar is included among the top collaborators of Gary Cutter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Cutter. Gary Cutter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Corboy, John R., Robert J. Fox, Gary Cutter, et al.. (2025). DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trial. Multiple Sclerosis Journal. 31(2). 159–173.
2.
Salter, Amber, Samantha Lancia, Gary Cutter, Robert J. Fox, & Ruth Ann Marrie. (2025). Post-acute sequela of COVID-19 infection in individuals with multiple sclerosis. Multiple Sclerosis Journal. 31(3). 314–323. 2 indexed citations
3.
Motl, Robert W., Charles H. Bombardier, Jennifer Duffecy, et al.. (2024). Study protocol: exercise training for treating major depressive disorder in multiple sclerosis. BMC Neurology. 24(1). 131–131. 1 indexed citations
4.
Salter, Amber, Alexander Keenan, Hoa H. Le, et al.. (2023). Severity and worsening of fatigue among individuals with multiple sclerosis. Multiple Sclerosis Journal - Experimental Translational and Clinical. 9(2). 3100530279–3100530279. 6 indexed citations
5.
Weinshenker, Brian G., Dean M. Wingerchuk, Ari Green, et al.. (2023). Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum. Multiple Sclerosis Journal. 29(8). 945–955. 5 indexed citations
6.
Baird, Jessica F., Gary Cutter, & Robert W. Motl. (2022). Do physical activity, cardiorespiratory fitness, and subcortical brain structures explain reduced walking performance in older adults with multiple sclerosis?. Multiple Sclerosis and Related Disorders. 60. 103702–103702. 3 indexed citations
7.
Koch, Marcus, Jop Mostert, Pavle Repovic, et al.. (2022). The timed 25-foot walk is a more sensitive outcome measure than the EDSS for PPMS trials: an analysis of the PROMISE clinical trial dataset. Journal of Neurology. 269(10). 5319–5327. 8 indexed citations
8.
Marrie, Ruth Ann, Leanne Kosowan, Gary Cutter, Robert J. Fox, & Amber Salter. (2022). Disparities in Telehealth Care in Multiple Sclerosis. Neurology Clinical Practice. 12(3). 223–233. 7 indexed citations
9.
Koch, Marcus, Luanne M. Metz, & Gary Cutter. (2021). An enrichment strategy for clinical trials in SPMS. Multiple Sclerosis Journal. 27(12). 1884–1893. 2 indexed citations
10.
Petracca, Maria, Gary Cutter, Sirio Cocozza, et al.. (2021). Cerebellar pathology and disability worsening in relapsing‐remitting multiple sclerosis: A retrospective analysis from the CombiRx trial. European Journal of Neurology. 29(2). 515–521. 4 indexed citations
11.
Salter, Amber, Robert J. Fox, Tuula Tyry, Gary Cutter, & Ruth Ann Marrie. (2020). New applications for independent activities of daily living in measuring disability in multiple sclerosis. Multiple Sclerosis Journal. 27(1). 97–106. 4 indexed citations
12.
Salter, Amber, et al.. (2019). Gender identity and sexual orientation affect health care satisfaction, but not utilization, in persons with Multiple Sclerosis. Multiple Sclerosis and Related Disorders. 37. 101440–101440. 12 indexed citations
13.
Sandroff, Brian M., Marcas M. Bamman, Gary Cutter, et al.. (2019). Protocol for a systematically-developed, phase I/II, single-blind randomized controlled trial of treadmill walking exercise training effects on cognition and brain function in persons with multiple sclerosis. Contemporary Clinical Trials. 87. 105878–105878. 14 indexed citations
14.
Motl, Robert W., Deborah Backus, Gary Cutter, et al.. (2019). Rationale and design of the STEP for MS Trial: Comparative effectiveness of Supervised versus Telerehabilitation Exercise Programs for Multiple Sclerosis. Contemporary Clinical Trials. 81. 110–122. 35 indexed citations
15.
Jaqueth, Jennifer, Zhenglin Hou, Peizhong Zheng, et al.. (2019). Fertility restoration of maize CMS‐C altered by a single amino acid substitution within the Rf4 bHLH transcription factor. The Plant Journal. 101(1). 101–111. 44 indexed citations
16.
Black, Laurence M., Jeremie M. Lever, Amie Traylor, et al.. (2018). Divergent effects of AKI to CKD models on inflammation and fibrosis. American Journal of Physiology-Renal Physiology. 315(4). F1107–F1118. 68 indexed citations
17.
Tamhane, Ashutosh, Andrew O. Westfall, Greer Burkholder, & Gary Cutter. (2016). Prevalence odds ratio versus prevalence ratio: choice comes with consequences. Statistics in Medicine. 35(30). 5730–5735. 238 indexed citations
18.
Cutter, Gary, et al.. (1995). A CASE CONTROL STUDY OF RISK FACTORS IN DEVELOPMENT OF FOCAL CORNEAL INFILTRATES WITH OVERLYING FLUORESCEIN STAINING.. Optometry and Vision Science. 72(SUPPLEMENT). 90–90. 1 indexed citations
19.
Chalmers, Robin L., et al.. (1995). ETHNICITY AS A RISK FACTOR FOR CONTACT LENS RELATED BIOMICRO-SCOPIC SIGNS.. Optometry and Vision Science. 72(SUPPLEMENT). 89–89. 3 indexed citations
20.
Cutter, Gary, et al.. (1994). CLINICAL PRESENTATION, PREVALENCE AND RISK FACTORS OF FOCAL INFILTRATES IN GENERAL EYE CARE PRACTICES. Optometry and Vision Science. 71(Supplement). 76–76. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026